Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Filters

Marcello Arca

Showing results (181-190 of 212) with videos related to

Pageof 22
Sort By:
American Journal of Preventive Cardiology|June 15, 2026
Potential impact on cholesterol goal achievement and predicted cardiovascular risk by the addition of ezetimibe and bempedoic acid on top of statins: a simulation from the SANTORINI studyKausik K Ray, Carlos Aguiar, Marcello Arca, et al.
Orphanet Journal of Rare Diseases|May 14, 2017
Neutral Lipid Storage Diseases: clinical/genetic features and natural history in a large cohort of Italian patientsElena Maria Pennisi, Marcello Arca, Enrico Bertini, et al.
European Journal of Preventive Cardiology|June 11, 2024
Use of combination therapy is associated with improved LDL cholesterol management: 1-year follow-up results from the European observational SANTORINI studyKausik K Ray, Carlos Aguiar, Marcello Arca, et al.
Journal of Cardiovascular Medicine (Hagerstown, Md.)|March 2, 2021
Non-high-density lipoprotein cholesterol versus low-density lipoprotein cholesterol in clinical practice: ANMCO position paperFurio Colivicchi, Stefania Angela Di Fusco, Marcello Arca, et al.
Journal of Lipid Research|September 24, 2013
Clinical characteristics and plasma lipids in subjects with familial combined hypolipidemia: a pooled analysisIlenia Minicocci, Sara Santini, Vito Cantisani, et al.
Advances in Therapy|April 23, 2017
Efficacy of Lomitapide in the Treatment of Familial Homozygous Hypercholesterolemia: Results of a Real-World Clinical Experience in ItalyLaura D'Erasmo, Angelo Baldassare Cefalù, Davide Noto, et al.
The New England Journal of Medicine|August 8, 2019
Volanesorsen and Triglyceride Levels in Familial Chylomicronemia SyndromeJoseph L Witztum, Daniel Gaudet, Steven D Freedman, et al.
Circulation. Cardiovascular Genetics|December 25, 2009
Mutations in the HFE gene and cardiovascular disease risk: an individual patient data meta-analysis of 53 880 subjectsDaphne L van der A, Maroeska M Rovers, Diederick E Grobbee, et al.
Circulation|September 15, 2023
ANGPTL3 Deficiency and Risk of Hepatic SteatosisLaura D'Erasmo, Michele Di Martino, Thomas Neufeld, et al.
Data in Brief|November 21, 2018
Characterisation of patients with familial chylomicronaemia syndrome (FCS) and multifactorial chylomicronaemia syndrome (MCS): Establishment of an FCS clinical diagnostic scorePhilippe Moulin, Robert Dufour, Maurizio Averna, et al.
Pageof 22

Showing results (181-190 of 212) with videos related to

Sort By:
Pageof 22
American Journal of Preventive Cardiology|June 15, 2026
Potential impact on cholesterol goal achievement and predicted cardiovascular risk by the addition of ezetimibe and bempedoic acid on top of statins: a simulation from the SANTORINI studyKausik K Ray, Carlos Aguiar, Marcello Arca, et al.
Orphanet Journal of Rare Diseases|May 14, 2017
Neutral Lipid Storage Diseases: clinical/genetic features and natural history in a large cohort of Italian patientsElena Maria Pennisi, Marcello Arca, Enrico Bertini, et al.
European Journal of Preventive Cardiology|June 11, 2024
Use of combination therapy is associated with improved LDL cholesterol management: 1-year follow-up results from the European observational SANTORINI studyKausik K Ray, Carlos Aguiar, Marcello Arca, et al.
Journal of Cardiovascular Medicine (Hagerstown, Md.)|March 2, 2021
Non-high-density lipoprotein cholesterol versus low-density lipoprotein cholesterol in clinical practice: ANMCO position paperFurio Colivicchi, Stefania Angela Di Fusco, Marcello Arca, et al.
Journal of Lipid Research|September 24, 2013
Clinical characteristics and plasma lipids in subjects with familial combined hypolipidemia: a pooled analysisIlenia Minicocci, Sara Santini, Vito Cantisani, et al.
Advances in Therapy|April 23, 2017
Efficacy of Lomitapide in the Treatment of Familial Homozygous Hypercholesterolemia: Results of a Real-World Clinical Experience in ItalyLaura D'Erasmo, Angelo Baldassare Cefalù, Davide Noto, et al.
The New England Journal of Medicine|August 8, 2019
Volanesorsen and Triglyceride Levels in Familial Chylomicronemia SyndromeJoseph L Witztum, Daniel Gaudet, Steven D Freedman, et al.
Circulation. Cardiovascular Genetics|December 25, 2009
Mutations in the HFE gene and cardiovascular disease risk: an individual patient data meta-analysis of 53 880 subjectsDaphne L van der A, Maroeska M Rovers, Diederick E Grobbee, et al.
Circulation|September 15, 2023
ANGPTL3 Deficiency and Risk of Hepatic SteatosisLaura D'Erasmo, Michele Di Martino, Thomas Neufeld, et al.
Data in Brief|November 21, 2018
Characterisation of patients with familial chylomicronaemia syndrome (FCS) and multifactorial chylomicronaemia syndrome (MCS): Establishment of an FCS clinical diagnostic scorePhilippe Moulin, Robert Dufour, Maurizio Averna, et al.
Pageof 22